Skip to main content

Blood glucose response to a calamansi drink in healthy adults: a non-randomised study

Abstract

Objective

Glycaemic Index (GI) ranks the body’s response to carbohydrate content in food such that high GI food increases postprandial blood glucose levels. One of the popular drinks at food and beverage outlets is a drink made from calamansi, a citrus that is believed not to induce an increase in blood glucose levels. In this non-randomised single-blind (participants) study, capillary blood from 10 healthy males were sampled following consumption of either glucose or the calamansi drink. The blood glucose measurements were then used to calculate the GI for the drink.

Results

The GI of the calamansi drink tested was calculated as 37, a value within the range of low GI foods.

Trial registration Clinical Trials identifier NCT04462016; Retrospectively registered on July 1, 2020.

Introduction

Diabetes mellitus is becoming a major public health concern worldwide [1]. Prolonged hyperglycaemia increases the risk of microvascular damage such as neuropathy that contributes to increased macrovascular complications such as ischaemic heart disease and ultimately reduced life expectancy [2]. As diabetics have increased hunger and food intake partly due to accelerated gastric emptying caused by absent or delayed secretion of insulin [3], normalising blood glucose slows its progression and prevents the development of complications [4]. Low glycaemic index (GI) food with a GI of 55 or lower, are slowly absorbed and produces lower peaks in blood glucose, which is useful for maintaining glycaemic control [5]. Decreased rate of glucose absorption reduces post-prandial rise in gut hormones such as incretins and insulin by maintaining suppression on free fatty acids (FFA) and counter regulatory responses, while at the same time achieving lower blood glucose concentrations. Over time, glucose is withdrawn from the circulation at a faster rate such that its levels return to baseline despite continued absorption from the gut [6].

Calamansi, which is also known as “calamondin” in America or “limau kasturi” in Malaysia [7], is consumed by many due to its potential health benefits [8] that includes the potential to lower post-prandial blood glucose [9]. Blood glucose response following consumption of a commercially sold calamansi drink was evaluated in this study. Data from this study will be helpful to consumers making drink choices in view of the increasing number diabetic individuals in the community [10]. Data from this study will also provide baseline information for further community-based investigations related to the GI of other foods.

Main text

Materials and methods

This non-randomised, single-blind (participants) study that was based on the report of a joint consultation between the Food and Agriculture Organization (FAO) and World Health Organisation (WHO) [11] was conducted between January and May of 2018 at the teaching laboratory of the Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak. Consenting 18 to 19-year-old males (n = 16) were pre-screened. Although all met the inclusion criteria, 10 were selected by simple randomisation for this two-arm study. All 10 participants were advised to abstain from alcohol and sleep for at least 6–8 h; fast for 8–10 h prior to each test. During each test, participants refrained from any vigorous activity that can alter blood glucose values; drinking water was provided throughout all tests. A total of 4 tests were conducted [11]: three for glucose (i.e., reference drink) and one for calamansi drink (i.e., test drink); tests were conducted within 1–2 weeks after the previous test. Each test lasted for 2 h. The calamansi drink used in this study was obtained from a commercial source (produced and marketed mainly in Sarawak, Malaysia). During the tests, participants were given unmarked drinking containers, in which both drinks had similar odour and appearance. The same 10 participants took part in all 4 tests.

Weight was measured using a digital weighing scale (Guardian Classic Digital Weighing Scale, Malaysia); height measured using a stadiometer (SECA, 213 Hamburg, Germany). The body mass index (BMI) was calculated using the weight (in kilograms) divided by height (in meter squared) formula and interpreted using the standard weight status categories for adults 18 years old and older [12]. Waist circumference [13]; urine dipstick test using Combur-Test® strips (Roche Diagnostics GmbH, Germany); capillary blood glucose levels measured using Accu-Chek® glucometer (Roche, Germany) with finger prick blood obtained using Accu-Chek® lancets (Roche, Germany) were also recorded [14].

Post-prandial blood glucose response measurements were done based on FAO/WHO [11]. Briefly, urine and capillary blood was measured at time “0”. The second measurement was taken 30 min post consumption of the reference drink, 75 g of glucose (Glucolin®, Malaysia) dissolved in 250 mL of drinking water. Urine and capillary blood were again tested at every 30-min intervals until the 120th min. The same procedures were repeated with the test drink, 250 mL of a commercially sourced calamansi drink.

The incremental area under the curve (IAUC) was used to calculate the area under the curve by applying the trapezoid rule in which the IAUC for the reference drink (glucose) was divided by the IAUC for calamansi followed by multiplication with 100 [11]. When a blood glucose value falls below the baseline, only the area above the fasting level is included and the area of the curve that was beneath the fasting concentration was excluded in the calculation. The following formula was used to calculate the GI [11]: 100 x (IAUC for test drink/IAUC for glucose drink).

Results and discussion

All 10 participants were 19-year-old males and non-smokers with mean weight of 64.5 kg ± 8.8 (standard error, SE); mean height of 169.02 cm ± 5.2; mean BMI of 22.50 kg/m2 ± 2.0; mean waist circumference of 77.7 cm ± 7.8; mean random blood glucose of 4.89 mmol/L ± 0.4; negative urine dipstick result. The pre-screen ensured the participants were suitable to take part in the study as their BMI was within the ranges of 18.5 to 24.99 kg/m2 [12]; waist circumference was not more than 102 cm [13] and random blood glucose were less than 7.8 mmol/L [2]. None of them were on any medications; none had family history of inherited diseases and none were diagnosed with pre-existing conditions such as human immunodeficiency virus (HIV) infection, hepatitis, inflammatory bowel diseases, diabetes mellitus, heart conditions (angina, arrhythmia or heart failure), kidney disease, blood disorders such as thalassaemia [6]; none had a history of acute medical or surgical event within the past 6 months.

As shown in Fig. 1, post-prandial blood glucose at 30 min after consumption of either reference drink (glucose) or test drink (calamansi) showed that blood glucose peaked at 9 mmol/L for reference drink (glucose) and 7.9 mmol/L for test drink (calamansi). This response was similar to studies with coconut water, custard apple, cashew and soursop [15]. At 1 h post-prandial, blood glucose levels started to decrease (7.7 mmol/L for reference drink and 5.5 mmol/L for test drink) and both returned to baseline at the last blood glucose measurement (5.6 mmol/L for reference drink and 4.7 mmol/L for test drink). This response was the same as those reported in studies testing blood glucose response to fruits such as watermelon, papaya and durian [16]. The decrease in glucose absorption 2-h post prandial is due to counter regulatory by hormones such as insulin and glucagon [6, 17]. The urine dipstick results for all 10 participants were negative at all sampling time points in all of the tests.

Fig. 1
figure1

Post-prandial blood glucose levels following consumption of the reference drink (glucose) or test drink (calamansi). Each point is the average blood glucose from 30 measurements for the reference drink and the average of 10 measurements for the test drink

The GI for the test drink (calamansi) was estimated as 37, showing that it has a low potential for raising blood glucose levels which can be inferred to cause a similar albeit slightly higher response in a diabetic individual [18, 19]. Food with low GI may slow the rate of gastric emptying as it is associated with prolonged small intestine transit time that reduces postprandial glucose absorption [20, 21]. The acidity contributed by the citric acid and ascorbic acid content in the calamansi drink, could also be a factor as acidity caused delayed gastric emptying [22]. The low GI could also be due to the content of the calamansi drink tested as calamansi fruit skin is rich in flavonoids [23] such as hesperidin and naringin that have been suggested to have hypoglycaemic properties in vitro [24] and in a diabetic rat model [8]. The fruit skin of calamansi also contains pectin, a natural fibre that can decrease the rise in blood glucose levels following a meal by shortening glucose contact time with the absorbing surface [25].

Limitations

  • The sample population. Future studies should also include pre-diabetic individuals and diabetic patients to enable comparison with demographic data.

  • The test drink. Although freshly prepared test drink would have been ideal, this was not feasible due to logistical constraints and this led to the choice of a commercially available drink.

  • The gender of the study participants. Future research should include both genders so that it is more representative of the general population.

Availability of data and materials

This could be made available from the corresponding author upon reasonable request.

Abbreviations

BMI:

Body mass index

FAO:

Food and Agriculture Organization

FFA:

Free fatty acids

GI:

Glycaemic index

HIV:

Human immunodeficiency virus

IAUC:

Incremental area under the curve

SE:

Standard error

WHO:

World Health Organisation

References

  1. 1.

    Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.

    PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a World Health Organization/International Diabetes Federation consultation. Geneva: World Health Organization; 2006.

    Google Scholar 

  3. 3.

    Aronoff SL, Berkowitz K, Shreiner B, Want L. Glucose metabolism and regulation: beyond insulin and glucagon. Diabetes Spectrum. 2004;17(3):183–90.

    Article  Google Scholar 

  4. 4.

    Thomas D, Elliott EJ. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus. Cochrane Database Syst Rev. 2009;1:CD006296.

    Google Scholar 

  5. 5.

    Marsh K, Barclay A, Colagiuri S, Brand-Miller J. Glycemic index and glycemic load of carbohydrates in the diabetes diet. Curr Diab Rep. 2011;11(2):120–7.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, et al. Glycemic index: overview of implications in health and disease. Am J Clin Nutr. 2002;76(1):266S–73S.

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Bin Y, Danping Z, Jingting S, Mun WC, Philip C, Shao QL, et al. Characteristics of calamansi (Citrus microcarpa). Part 2: volatiles, physicochemical properties and non-volatiles in the juice. Food Chem. 2012;134(2):696–703.

    Article  Google Scholar 

  8. 8.

    Morte MYT, Acero LH. Potential of calamansi (Citrofortunella microcarpa) fruit peels extract in lowering the glucose level of streptozotocin induced albino rats (Rattus albus). Int J Food Eng. 2017;1(3):29–34.

    Google Scholar 

  9. 9.

    Abu-gabal NS, Abd-alla HI, Mohamed NZ, Aly HF, Shalaby NMM. Phytophenolics composition, hypolipidemic, hypoglycemic, and antioxidant effects of the leaves of Fortunella japonica (Thunb.) Swingle. Int J Pharm Pharm Sci. 2015;7(12):55–63.

    CAS  Google Scholar 

  10. 10.

    Tee ES, Yap RWK. Type 2 diabetes mellitus in Malaysia: current trends and risk factors. Eur J Clin Nutr. 2017;71(7):844–9.

    PubMed  Article  Google Scholar 

  11. 11.

    Carbohydrates in human nutrition. Report of a Joint Food and Agriculture Organization/World Health Organisation Expert Consultation. Rome; 1998. Report No.: 0254-4725 (Print) 0254-4725 (Linking).

  12. 12.

    Azmi MY Jr, Junidah R, Siti Mariam A, Safiah MY, Fatimah S, Norimah AK, et al. Body mass index (BMI) of adults: findings of the Malaysian Adult Nutrition Survey (MANS). Malays J Nutr. 2009;15(2):97–119.

    PubMed  Google Scholar 

  13. 13.

    World Health Organisation. Waist circumference and waist–hip ratio: report of a WHO expert consultation. Geneva: World Health Organisation; 2008.

    Google Scholar 

  14. 14.

    MoH Malaysia. Section 2: screening and diagnosis. 5th ed. Malaysia: Ministry of Health Malaysia; 2015. p. 3–7.

    Google Scholar 

  15. 15.

    Passos TU, Alves H, Sampaio DC, Olganê M, Sabry D, Luisa M, et al. Glycemic index and glycemic load of tropical fruits and the potential risk for chronic diseases. Food Sci Technol Int. 2015;35(1):66–73.

    Article  Google Scholar 

  16. 16.

    Robert SD, Ismail AA, Winn T, Wolever TM. Glycemic index of common Malaysian fruits. Asia Pac J Clin Nutr. 2008;17(1):35–9.

    CAS  PubMed  Google Scholar 

  17. 17.

    Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA. 2002;287(18):2414–23.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Jenkins DJ, Wolever TM, Taylor RH, Ghafari H, Jenkins AL, Barker H, et al. Rate of digestion of foods and postprandial glycaemia in normal and diabetic subjects. Br Med J. 1980;281(6232):14–7.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Zafar MI, Mills KE, Zheng J, Regmi A, Hu SQ, Gou L, et al. Low-glycemic index diets as an intervention for diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2019;110(4):891–902.

    PubMed  Article  Google Scholar 

  20. 20.

    Delport E. A comparison of the glycemic index (GI) results obtained from two techniques on a group of healthy and a group of mixed subjects. Pretoria: University Van Pretoria; 2006.

    Google Scholar 

  21. 21.

    Muller M, Canfora EE, Blaak EE. Gastrointestinal transit time, glucose homeostasis and metabolic health: modulation by dietary fibers. Nutrients. 2018;10(3):275.

    PubMed Central  Article  Google Scholar 

  22. 22.

    Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002;76(1):5–56.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Lou S-N, Hsu Y-S, Ho C-T. Flavonoid compositions and antioxidant activity of calamondin extracts prepared using different solvents. J Food Drug Anal. 2014;22(3):290–5.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Lim SM, Loh SP. In vitro antioxidant capacities and antidiabetic properties of phenolic extracts from selected citrus peels. Int Food Res J. 2016;23(1):211–9.

    CAS  Google Scholar 

  25. 25.

    Cherbut C. Role of gastrointestinal motility in the delay of absorption by dietary fibre. Eur J Clin Nutr. 1995;49(Suppl 3):S74–80.

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank the Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak for permission to conduct this study. This research was conducted in fulfilment of the Elective 1 research course (MDP20505) requirement for MS, TA & ZAW (second year, pre-clinical phase undergraduate Medical students).

Declarations

This manuscript adheres to Consolidated Standards of Reporting Trials (CONSORT) guidelines.

Funding

This study was conducted without any specific financial support from a funding agency.

Author information

Affiliations

Authors

Contributions

AS conceptualized & designed the study; supervised data collection, analysis & interpretation; drafted the manuscript. MS, TA & ZAW conducted the experiments. LL provided technical support on study design & assisted in data collection. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Angela Siner.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Research Ethics Committee, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak (UNIMAS/NC-21.02/03-02 Jld.2 (118)). All participants were given oral and written information on study procedures and risks prior to the start of the study. Informed consent through the completion of consent forms were obtained prior to the pre-screen. Only eligible participants, who consented to participate, took part in the subsequent tests. All samples were de-identified at all points of data collection.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Siner, A., Sevanesan, M.S., Ambomai, T. et al. Blood glucose response to a calamansi drink in healthy adults: a non-randomised study. BMC Res Notes 13, 404 (2020). https://doi.org/10.1186/s13104-020-05250-8

Download citation

Keywords

  • Calamansi
  • Glycaemic index
  • Post-prandial blood glucose